Abstract
Systemic fungal infections have increased over time due to the rise in the at-risk population, which includes immunocompromised patients, those submitted to organ transplantation or undergoing chemotherapy. Clinically available antifungals are limited since some of them have important side effects, being toxic to the host cells, and some can quell filamentous fungi, but their activity against pathogenic yeasts is not killing but controlling their multiplication. Antimicrobial peptides are multifunctional molecules expressed by several microorganisms or synthetized by different techniques. They can play a central role in infection and inflammation. Some of their other effects include chemotactic and immunomodulating activities and wound repair. Antimicrobial peptides (AMPs) can be isolated from a large variety of microorganisms, such as plants, vertebrates, insects, bacteria, and fungi. They are classified into categories according to their amino acid composition, size, and conformational structures, and naturally occurring peptides can be synthetized. Solid-phase peptide synthesis allows the use of nonproteinogenic amino acids and permits changes in structural and physicochemical properties. In these terms, peptide engineering is a useful tool to adjust features such as net charge, surface hydrophobicity, and polarity, and it may also optimize activity and overcome the limitations inherent to natural peptides. AMPs have potential applications in antifungal therapeutics in human health, and recent uses of synthetic AMPs against fungal infections are discussed in this article.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- ABP-dHC:
-
Antimicrobial peptide drury Hyphantria cunea
- AIDS:
-
Acquired immune deficiency syndrome
- AMPs:
-
Antimicrobial peptides
- ATP:
-
Adenosine triphosphate
- BMAP:
-
Bovine myeloid antimicrobial peptides
- DNA:
-
Desoxyribonucleic acid
- EDMC:
-
Electrostatically driven Monte Carlo
- FDA:
-
US Food and Drug Administration
- GPI:
-
Glycosylphosphatidylinositol
- HIV:
-
Human immunodeficiency virus
- hLF:
-
Human lactoferrin
- HNP:
-
Human neutrophils peptides
- HP:
-
Human defensins
- MDR:
-
Multidrug-resistant
- MPTP:
-
Mitochondrial permeability forming transition pores
- PI:
-
Propidium iodate
- PMAP:
-
Porcine myeloid antimicrobial peptide
- SMAP:
-
Sheep myeloid antimicrobial peptide
References
Abdel-Wahab YH, Patterson S, Flatt PR, Conlon JM (2010) Brevinin-2-related peptide and its [D4K] analogue stimulate insulin release in vitro and improve glucose tolerance in mice fed a high fat diet. Hormone Metabol Res Horm Stoffwechselforschung Horm Metab 42(9):652–656. doi:10.1055/s-0030-1254126
Alekseeva L, Huet D, Femenia F, Mouyna I, Abdelouahab M, Cagna A et al (2009) Inducible expression of beta defensins by human respiratory epithelial cells exposed to Aspergillus fumigatus organisms. BMC Microbiol 9:33. doi:10.1186/1471-2180-9-33
Arora R, Gupta D, Goyal J, Kaur R (2011) Voriconazole versus natamycin as primary treatment in fungal corneal ulcers. Clin Experiment Ophthalmol 39(5):434–440. doi:10.1111/j.1442-9071.2010.02473.x
Baev D, Li X, Edgerton M (2001) Genetically engineered human salivary histatin genes are functional in Candida albicans: development of a new system for studying histatin candidacidal activity. Microbiology 147(Pt 12):3323–3334
Bai Y, Liu S, Jiang P, Zhou L, Li J, Tang C et al (2009) Structure-dependent charge density as a determinant of antimicrobial activity of peptide analogues of defensin. Biochemistry 48(30):7229–7239. doi:10.1021/bi900670d
Barbault F, Landon C, Guenneugues M, Meyer JP, Schott V, Dimarcq JL et al (2003) Solution structure of Alo-3: a new knottin-type antifungal peptide from the insect Acrocinus longimanus. Biochemistry 42(49):14434–14442. doi:10.1021/bi035400o
Benincasa M, Scocchi M, Pacor S, Tossi A, Nobili D, Basaglia G et al (2006) Fungicidal activity of five cathelicidin peptides against clinically isolated yeasts. J Antimicrob Chemother 58(5):950–959. doi:10.1093/jac/dkl382
Blondelle SE, Lohner K (2010) Optimization and high-throughput screening of antimicrobial peptides. Curr Pharm Des 16(28):3204–3211
Bowman SM, Free SJ (2006) The structure and synthesis of the fungal cell wall. BioEssays: News Rev Mol Cell Dev Biol 28(8):799–808. doi:10.1002/bies.20441
Brogden KA (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3(3):238–250. doi:10.1038/nrmicro1098
Carotenuto A, Malfi S, Saviello MR, Campiglia P, Gomez-Monterrey I, Mangoni ML et al (2008) A different molecular mechanism underlying antimicrobial and hemolytic actions of temporins A and L. J Med Chem 51(8):2354–2362. doi:10.1021/jm701604t
Chae JH, Kurokawa K, So YI, Hwang HO, Kim MS, Park JW et al (2012) Purification and characterization of tenecin 4, a new anti-Gram-negative bacterial peptide, from the beetle Tenebrio molitor. Dev Comp Immunol 36(3):540–546. doi:10.1016/j.dci.2011.09.010
Charlton ST, Whetstone J, Fayinka ST, Read KD, Illum L, Davis SS (2008) Evaluation of direct transport pathways of glycine receptor antagonists and an angiotensin antagonist from the nasal cavity to the central nervous system in the rat model. Pharm Res 25(7):1531–1543. doi:10.1007/s11095-008-9550-2
Chen C, Wu S, Li X, Zhang X, Yan M (2011) [Structure, function and molecular design strategies of antibacterial peptide SMAP-29: a review]. Sheng Wu Gong Cheng Xue Bao Chin J Biotechnol 27(6):846–859
Conlon JM, Sonnevend A, Patel M, Davidson C, Nielsen PF, Pal T et al (2003) Isolation of peptides of the brevinin-1 family with potent candidacidal activity from the skin secretions of the frog Rana boylii. J Pept Res 62(5):207–213
Da Silva P, Jouvensal L, Lamberty M, Bulet P, Caille A, Vovelle F (2003) Solution structure of termicin, an antimicrobial peptide from the termite Pseudacanthotermes spiniger. Protein Sci: Publ Protein Soc 12(3):438–446. doi:10.1110/ps.0228303
Dawson RM, Liu CQ (2010) Disulphide bonds of the peptide protegrin-1 are not essential for antimicrobial activity and haemolytic activity. Int J Antimicrob Agents 36(6):579–580. doi:10.1016/j.ijantimicag.2010.08.011
Dawson RM, Liu CQ (2011) Analogues of peptide SMAP-29 with comparable antimicrobial potency and reduced cytotoxicity. Int J Antimicrob Agents 37(5):432–437. doi:10.1016/j.ijantimicag.2011.01.007
Day CL, Anderson BF, Tweedie JW, Baker EN (1993) Structure of the recombinant N-terminal lobe of human lactoferrin at 2.0 A resolution. J Mol Biol 232(4):1084–1100. doi:10.1006/jmbi.1993.1462
De Lucca AJ, Bland JM, Jacks TJ, Grimm C, Cleveland TE, Walsh TJ (1997) Fungicidal activity of cecropin A. Antimicrob Agents Chemother 41(2):481–483
De Lucca AJ, Bland JM, Vigo CB, Jacks TJ, Peter J, Walsh TJ (2000) D-cecropin B: proteolytic resistance, lethality for pathogenic fungi and binding properties. Med Mycol 38(4):301–308
De Smet K, Contreras R (2005) Human antimicrobial peptides: defensins, cathelicidins and histatins. Biotechnol Lett 27(18):1337–1347. doi:10.1007/s10529-005-0936-5
Del Sal G, Storici P, Schneider C, Romeo D, Zanetti M (1992) cDNA cloning of the neutrophil bactericidal peptide indolicidin. Biochem Biophys Res Commun 187(1):467–472
den Hertog AL, van Marle J, van Veen HA, Van’t Hof W, Bolscher JG, Veerman EC et al (2005) Candidacidal effects of two antimicrobial peptides: histatin 5 causes small membrane defects, but LL-37 causes massive disruption of the cell membrane. Biochem J 388(Pt 2):689–695. doi:10.1042/BJ20042099
den Hertog AL, van Marle J, Veerman EC, Valentijn-Benz M, Nazmi K, Kalay H et al (2006) The human cathelicidin peptide LL-37 and truncated variants induce segregation of lipids and proteins in the plasma membrane of Candida albicans. Biol Chem 387(10–11):1495–1502. doi:10.1515/BC.2006.187
Dhople V, Krukemeyer A, Ramamoorthy A (2006) The human beta-defensin-3, an antibacterial peptide with multiple biological functions. Biochim Biophys Acta 1758(9):1499–1512. doi:10.1016/j.bbamem.2006.07.007
Driscoll J, Zuo Y, Xu T, Choi JR, Troxler RF, Oppenheim FG (1995) Functional comparison of native and recombinant human salivary histatin 1. J Dent Res 74(12):1837–1844
Durr UH, Sudheendra US, Ramamoorthy A (2006) LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim Biophys Acta 1758(9):1408–1425. doi:10.1016/j.bbamem.2006.03.030
Eckert R (2011) Road to clinical efficacy: challenges and novel strategies for antimicrobial peptide development. Future Microbiol 6(6):635–651. doi:10.2217/fmb.11.27
Edgerton M, Koshlukova SE, Lo TE, Chrzan BG, Straubinger RM, Raj PA (1998) Candidacidal activity of salivary histatins. Identification of a histatin 5-binding protein on Candida albicans. J Biol Chem 273(32):20438–20447
Fahrner RL, Dieckmann T, Harwig SS, Lehrer RI, Eisenberg D, Feigon J (1996) Solution structure of protegrin-1, a broad-spectrum antimicrobial peptide from porcine leukocytes. Chem Biol 3(7):543–550
Fanos V, Cataldi L (2001) Renal transport of antibiotics and nephrotoxicity: a review. J Chemother 13(5):461–472. doi:10.1179/joc.2001.13.5.461
Fisher MC, Henk DA, Briggs CJ, Brownstein JS, Madoff LC, McCraw SL et al (2012) Emerging fungal threats to animal, plant and ecosystem health. Nature 484(7393):186–194. doi:10.1038/nature10947
Fitzgerald DH, Coleman DC, O’Connell BC (2003) Binding, internalisation and degradation of histatin 3 in histatin-resistant derivatives of Candida albicans. FEMS Microbiol Lett 220(2):247–253
Fjell CD, Hiss JA, Hancock RE, Schneider G (2012) Designing antimicrobial peptides: form follows function. Nat Rev Drug Discov 11(1):37–51. doi:10.1038/nrd3591
Fontaine T, Simenel C, Dubreucq G, Adam O, Delepierre M, Lemoine J et al (2000) Molecular organization of the alkali-insoluble fraction of Aspergillus fumigatus cell wall. J Biol Chem 275(36):27594–27607. doi:10.1074/jbc.M909975199
Fosgerau K, Hoffmann T (2015) Peptide therapeutics: current status and future directions. Drug Discov Today 20(1):122–128. doi:10.1016/j.drudis.2014.10.003
Fox JL (2013) Antimicrobial peptides stage a comeback. Nat Biotechnol 31(5):379–382. doi:10.1038/nbt.2572
Friedrich CL, Rozek A, Patrzykat A, Hancock RE (2001) Structure and mechanism of action of an indolicidin peptide derivative with improved activity against gram-positive bacteria. J Biol Chem 276(26):24015–24022. doi:10.1074/jbc.M009691200
Fukuoka T, Johnston DA, Winslow CA, de Groot MJ, Burt C, Hitchcock CA et al (2003) Genetic basis for differential activities of fluconazole and voriconazole against Candida krusei. Antimicrob Agents Chemother 47(4):1213–1219
Gabrielska J, Gagos M, Gubernator J, Gruszecki WI (2006) Binding of antibiotic amphotericin B to lipid membranes: a 1H NMR study. FEBS Lett 580(11):2677–2685. doi:10.1016/j.febslet.2006.04.021
Ganz T (2003) Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 3(9):710–720. doi:10.1038/nri1180
Ganz T (2005) Defensins and other antimicrobial peptides: a historical perspective and an update. Comb Chem High Throughput Screen 8(3):209–217
Ganz T, Lehrer RI (1995) Defensins. Pharmacol Ther 66(2):191–205
Garibotto FM, Garro AD, Masman MF, Rodriguez AM, Luiten PG, Raimondi M et al (2010) New small-size peptides possessing antifungal activity. Bioorg Med Chem 18(1):158–167. doi:10.1016/j.bmc.2009.11.009
Gennaro R, Zanetti M (2000) Structural features and biological activities of the cathelicidin-derived antimicrobial peptides. Biopolymers 55(1):31–49. doi:10.1002/1097-0282(2000)55:1<31::AID-BIP40>3.0.CO;2-9
Goraya J, Wang Y, Li Z, O’Flaherty M, Knoop FC, Platz JE et al (2000) Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens. Eur J Biochem/FEBS 267(3):894–900
Gupta V, Hwang BH, Lee J, Anselmo AC, Doshi N, Mitragotri S (2013) Mucoadhesive intestinal devices for oral delivery of salmon calcitonin. J Control Release: Off J Control Release Soc 172(3):753–762. doi:10.1016/j.jconrel.2013.09.004
Gyurko C, Lendenmann U, Troxler RF, Oppenheim FG (2000) Candida albicans mutants deficient in respiration are resistant to the small cationic salivary antimicrobial peptide histatin 5. Antimicrob Agents Chemother 44(2):348–354
Hale JD, Hancock RE (2007) Alternative mechanisms of action of cationic antimicrobial peptides on bacteria. Expert Rev Anti Infect Ther 5(6):951–959. doi:10.1586/14787210.5.6.951
Hancock RE, Patrzykat A (2002) Clinical development of cationic antimicrobial peptides: from natural to novel antibiotics. Curr Drug Targets Infect Disord 2(1):79–83
Hancock RE, Rozek A (2002) Role of membranes in the activities of antimicrobial cationic peptides. FEMS Microbiol Lett 206(2):143–149
Hancock RE, Nijnik A, Philpott DJ (2012) Modulating immunity as a therapy for bacterial infections. Nat Rev Microbiol 10(4):243–254. doi:10.1038/nrmicro2745
Hay DI (1975) Fractionation of human parotid salivary proteins and the isolation of an histidine-rich acidic peptide which shows high affinity for hydroxyapatite surfaces. Arch Oral Biol 20(9):553–558
Helmerhorst EJ, Van’t Hof W, Veerman EC, Simoons-Smit I, Nieuw Amerongen AV (1997) Synthetic histatin analogues with broad-spectrum antimicrobial activity. Biochem J 326(Pt 1):39–45
Helmerhorst EJ, Reijnders IM, van’t Hof W, Simoons-Smit I, Veerman EC, Amerongen AV (1999a) Amphotericin B- and fluconazole-resistant Candida spp., Aspergillus fumigatus, and other newly emerging pathogenic fungi are susceptible to basic antifungal peptides. Antimicrob Agents Chemother 43(3):702–704
Helmerhorst EJ, Breeuwer P, van’t Hof W, Walgreen-Weterings E, Oomen LC, Veerman EC et al (1999b) The cellular target of histatin 5 on Candida albicans is the energized mitochondrion. J Biol Chem 274(11):7286–7291
Helmerhorst EJ, Troxler RF, Oppenheim FG (2001) The human salivary peptide histatin 5 exerts its antifungal activity through the formation of reactive oxygen species. Proc Natl Acad Sci U S A 98(25):14637–14642. doi:10.1073/pnas.141366998
Helmerhorst EJ, Murphy MP, Troxler RF, Oppenheim FG (2002) Characterization of the mitochondrial respiratory pathways in Candida albicans. Biochim Biophys Acta 1556(1):73–80
Holt A, Killian JA (2010) Orientation and dynamics of transmembrane peptides: the power of simple models. Eur Biophys J: EBJ 39(4):609–621. doi:10.1007/s00249-009-0567-1
Hsu CH, Chen C, Jou ML, Lee AY, Lin YC, Yu YP et al (2005) Structural and DNA-binding studies on the bovine antimicrobial peptide, indolicidin: evidence for multiple conformations involved in binding to membranes and DNA. Nucleic Acids Res 33(13):4053–4064. doi:10.1093/nar/gki725
Hujakka H, Ratilainen J, Korjamo T, Lankinen H, Kuusela P, Santa H et al (2001) Synthesis and antimicrobial activity of the symmetric dimeric form of Temporin A based on 3-N, N-di(3-aminopropyl)amino propanoic acid as the branching unit. Bioorg Med Chem 9(6):1601–1607
Jenssen H, Hamill P, Hancock RE (2006) Peptide antimicrobial agents. Clin Microbiol Rev 19(3):491–511. doi:10.1128/CMR.00056-05
Joly S, Maze C, McCray PB Jr, Guthmiller JM (2004) Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms. J Clin Microbiol 42(3):1024–1029
Kahn A, Carey EJ, Blair JE (2014) Universal fungal prophylaxis and risk of coccidioidomycosis in liver transplant recipients living in an endemic area. Liver Transplant: Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc. doi:10.1002/lt.24055
Kaminski DM (2014) Recent progress in the study of the interactions of amphotericin B with cholesterol and ergosterol in lipid environments. Eur Biophys J: EBJ 43(10–11):453–467. doi:10.1007/s00249-014-0983-8
Kaspar AA, Reichert JM (2013) Future directions for peptide therapeutics development. Drug Discov Today 18(17–18):807–817. doi:10.1016/j.drudis.2013.05.011
Kavanagh K, Dowd S (2004) Histatins: antimicrobial peptides with therapeutic potential. J Pharm Pharmacol 56(3):285–289. doi:10.1211/0022357022971
Kim DH, Lee YT, Lee YJ, Chung JH, Lee BL, Choi BS et al (1998) Bacterial expression of tenecin 3, an insect antifungal protein isolated from Tenebrio molitor, and its efficient purification. Mol Cells 8(6):786–789
Kim DH, Lee DG, Kim KL, Lee Y (2001) Internalization of tenecin 3 by a fungal cellular process is essential for its fungicidal effect on Candida albicans. Eur J Biochem/FEBS 268(16):4449–4458
Knappe D, Henklein P, Hoffmann R, Hilpert K (2010) Easy strategy to protect antimicrobial peptides from fast degradation in serum. Antimicrob Agents Chemother 54(9):4003–4005. doi:10.1128/AAC.00300-10
Kosciuczuk EM, Lisowski P, Jarczak J, Strzalkowska N, Jozwik A, Horbanczuk J et al (2012) Cathelicidins: family of antimicrobial peptides. A review. Mol Biol Rep 39(12):10957–10970. doi:10.1007/s11033-012-1997-x
Koshlukova SE, Lloyd TL, Araujo MW, Edgerton M (1999) Salivary histatin 5 induces non-lytic release of ATP from Candida albicans leading to cell death. J Biol Chem 274(27):18872–18879
Koshlukova SE, Araujo MW, Baev D, Edgerton M (2000) Released ATP is an extracellular cytotoxic mediator in salivary histatin 5-induced killing of Candida albicans. Infect Immun 68(12):6848–6856
Kumar R, Chadha S, Saraswat D, Bajwa JS, Li RA, Conti HR et al (2011) Histatin 5 uptake by Candida albicans utilizes polyamine transporters Dur3 and Dur31 proteins. J Biol Chem 286(51):43748–43758. doi:10.1074/jbc.M111.311175
Kwon MY, Hong SY, Lee KH (1998) Structure-activity analysis of brevinin 1E amide, an antimicrobial peptide from Rana esculenta. Biochim Biophys Acta 1387(1–2):239–248
Ladokhin AS, White SH (2001) ‘Detergent-like’ permeabilization of anionic lipid vesicles by melittin. Biochim Biophys Acta 1514(2):253–260
Lakshminarayanan R, Liu S, Li J, Nandhakumar M, Aung TT, Goh E et al (2014) Synthetic multivalent antifungal peptides effective against fungi. PLoS One 9(2):e87730. doi:10.1371/journal.pone.0087730
Lamberty M, Zachary D, Lanot R, Bordereau C, Robert A, Hoffmann JA et al (2001) Insect immunity. Constitutive expression of a cysteine-rich antifungal and a linear antibacterial peptide in a termite insect. J Biol Chem 276(6):4085–4092. doi:10.1074/jbc.M002998200
Lee SY, Moon HJ, Kurata S, Natori S, Lee BL (1995) Purification and cDNA cloning of an antifungal protein from the hemolymph of Holotrichia diomphalia larvae. Biol Pharm Bull 18(8):1049–1052
Lee DG, Kim DH, Park Y, Kim HK, Kim HN, Shin YK et al (2001) Fungicidal effect of antimicrobial peptide, PMAP-23, isolated from porcine myeloid against Candida albicans. Biochem Biophys Res Commun 282(2):570–574. doi:10.1006/bbrc.2001.4602
Lee DG, Kim PI, Park Y, Park SC, Woo ER, Hahm KS (2002a) Antifungal mechanism of SMAP-29 (1–18) isolated from sheep myeloid mRNA against Trichosporon beigelii. Biochem Biophys Res Commun 295(3):591–596
Lee DG, Kim PI, Park Y, Woo ER, Choi JS, Choi CH et al (2002b) Design of novel peptide analogs with potent fungicidal activity, based on PMAP-23 antimicrobial peptide isolated from porcine myeloid. Biochem Biophys Res Commun 293(1):231–238. doi:10.1016/S0006-291X(02)00222-X
Lee DG, Kim HK, Kim SA, Park Y, Park SC, Jang SH et al (2003) Fungicidal effect of indolicidin and its interaction with phospholipid membranes. Biochem Biophys Res Commun 305(2):305–310
Legrand D, Pierce A, Elass E, Carpentier M, Mariller C, Mazurier J (2008) Lactoferrin structure and functions. Adv Exp Med Biol 606:163–194. doi:10.1007/978-0-387-74087-4_6
Lehrer RI, Ganz T, Szklarek D, Selsted ME (1988) Modulation of the in vitro candidacidal activity of human neutrophil defensins by target cell metabolism and divalent cations. J Clin Invest 81(6):1829–1835. doi:10.1172/JCI113527
Levay PF, Viljoen M (1995) Lactoferrin: a general review. Haematologica 80(3):252–267
Li XS, Sun JN, Okamoto-Shibayama K, Edgerton M (2006) Candida albicans cell wall ssa proteins bind and facilitate import of salivary histatin 5 required for toxicity. J Biol Chem 281(32):22453–22463. doi:10.1074/jbc.M604064200
Lim K, Chua RR, Ho B, Tambyah PA, Hadinoto K, Leong SS (2015) Development of a catheter functionalized by a polydopamine peptide coating with antimicrobial and antibiofilm properties. Acta Biomater 15:127–138. doi:10.1016/j.actbio.2014.12.015
Liu AY, Destoumieux D, Wong AV, Park CH, Valore EV, Liu L et al (2002) Human beta-defensin-2 production in keratinocytes is regulated by interleukin-1, bacteria, and the state of differentiation. J Invest Dermatol 118(2):275–281. doi:10.1046/j.0022-202x.2001.01651.x
Lopez-Garcia B, Lee PH, Yamasaki K, Gallo RL (2005) Anti-fungal activity of cathelicidins and their potential role in Candida albicans skin infection. J Invest Dermatol 125(1):108–115. doi:10.1111/j.0022-202X.2005.23713.x
Lupetti A, Paulusma-Annema A, Welling MM, Senesi S, van Dissel JT, Nibbering PH (2000) Candidacidal activities of human lactoferrin peptides derived from the N terminus. Antimicrob Agents Chemother 44(12):3257–3263
Mangoni ML, Rinaldi AC, Di Giulio A, Mignogna G, Bozzi A, Barra D et al (2000) Structure-function relationships of temporins, small antimicrobial peptides from amphibian skin. Eur J Biochem/FEBS 267(5):1447–1454
Marenah L, Flatt PR, Orr DF, McClean S, Shaw C, Abdel-Wahab YH (2004) Brevinin-1 and multiple insulin-releasing peptides in the skin of the frog Rana palustris. J Endocrinol 181(2):347–354
Martinez J, Temesgen Z (2006) Opportunistic infections in patients with HIV and AIDS. Fungal and parasitic infections. J Med Liban Liban Med J 54(2):84–90
Marukutira T, Huprikar S, Azie N, Quan SP, Meier-Kriesche HU, Horn DL (2014) Clinical characteristics and outcomes in 303 HIV-infected patients with invasive fungal infections: data from the Prospective Antifungal Therapy Alliance registry, a multicenter, observational study. Hiv/Aids 6:39–47. doi:10.2147/HIV.S53910
Masman MF, Rodriguez AM, Raimondi M, Zacchino SA, Luiten PG, Somlai C et al (2009) Penetratin and derivatives acting as antifungal agents. Eur J Med Chem 44(1):212–228. doi:10.1016/j.ejmech.2008.02.019
Matsuzaki K (2009) Control of cell selectivity of antimicrobial peptides. Biochim Biophys Acta 1788(8):1687–1692. doi:10.1016/j.bbamem.2008.09.013
Maurya IK, Pathak S, Sharma M, Sanwal H, Chaudhary P, Tupe S et al (2011) Antifungal activity of novel synthetic peptides by accumulation of reactive oxygen species (ROS) and disruption of cell wall against Candida albicans. Peptides 32(8):1732–1740. doi:10.1016/j.peptides.2011.06.003
McNeil MM, Nash SL, Hajjeh RA, Phelan MA, Conn LA, Plikaytis BD et al (2001) Trends in mortality due to invasive mycotic diseases in the United States, 1980–1997. Clin Infect Dis: Off Publ Infect Dis Soc Am 33(5):641–647. doi:10.1086/322606
Milletti F (2012) Cell-penetrating peptides: classes, origin, and current landscape. Drug Discov Today 17(15–16):850–860, doi:http://dx.doi.org/10.1016/j.drudis.2012.03.002
Moore A (2003) The big and small of drug discovery. EMBO Rep 4(2):114–117. doi:10.1038/sj.embor.embor748
Morikawa N, Hagiwara K, Nakajima T (1992) Brevinin-1 and -2, unique antimicrobial peptides from the skin of the frog, Rana brevipoda porsa. Biochem Biophys Res Commun 189(1):184–190
Murakami Y, Nagata H, Shizukuishi S, Nakashima K, Okawa T, Takigawa M et al (1994) Histatin as a synergistic stimulator with epidermal growth factor of rabbit chondrocyte proliferation. Biochem Biophys Res Commun 198(1):274–280. doi:10.1006/bbrc.1994.1038
Neville F, Ivankin A, Konovalov O, Gidalevitz D (2010) A comparative study on the interactions of SMAP-29 with lipid monolayers. Biochim Biophys Acta 1798(5):851–860. doi:10.1016/j.bbamem.2009.09.017
Nguyen LT, Schibli DJ, Vogel HJ (2005) Structural studies and model membrane interactions of two peptides derived from bovine lactoferricin. J Pept Sci: Off Publ Eur Pept Soc 11(7):379–389. doi:10.1002/psc.629
Nguyen LT, Chau JK, Perry NA, de Boer L, Zaat SA, Vogel HJ (2010) Serum stabilities of short tryptophan- and arginine-rich antimicrobial peptide analogs. PLoS One 5(9):e12684. doi:10.1371/journal.pone.0012684
Nguyen LT, Haney EF, Vogel HJ (2011) The expanding scope of antimicrobial peptide structures and their modes of action. Trends Biotechnol 29(9):464–472, doi:http://dx.doi.org/10.1016/j.tibtech.2011.05.001
Novkovic M, Simunic J, Bojovic V, Tossi A, Juretic D (2012) DADP: the database of anuran defense peptides. Bioinformatics 28(10):1406–1407. doi:10.1093/bioinformatics/bts141
Oppenheim FG, Yang YC, Diamond RD, Hyslop D, Offner GD, Troxler RF (1986) The primary structure and functional characterization of the neutral histidine-rich polypeptide from human parotid secretion. J Biol Chem 261(3):1177–1182
Oppenheim JJ, Biragyn A, Kwak LW, Yang D (2003) Roles of antimicrobial peptides such as defensins in innate and adaptive immunity. Ann Rheum Dis 62(Suppl 2):ii17–ii21
Ostrosky-Zeichner L, Casadevall A, Galgiani JN, Odds FC, Rex JH (2010) An insight into the antifungal pipeline: selected new molecules and beyond. Nat Rev Drug Discov 9(9):719–727. doi:10.1038/nrd3074
Otvos L Jr, Wade JD (2014) Current challenges in peptide-based drug discovery. Front Chem 2:62. doi:10.3389/fchem.2014.00062
Oudhoff MJ, Blaauboer ME, Nazmi K, Scheres N, Bolscher JG, Veerman EC (2010) The role of salivary histatin and the human cathelicidin LL-37 in wound healing and innate immunity. Biol Chem 391(5):541–548. doi:10.1515/BC.2010.057
Pal T, Abraham B, Sonnevend A, Jumaa P, Conlon JM (2006) Brevinin-1BYa: a naturally occurring peptide from frog skin with broad-spectrum antibacterial and antifungal properties. Int J Antimicrob Agents 27(6):525–529. doi:10.1016/j.ijantimicag.2006.01.010
Park SH, Kim HE, Kim CM, Yun HJ, Choi EC, Lee BJ (2002a) Role of proline, cysteine and a disulphide bridge in the structure and activity of the anti-microbial peptide gaegurin 5. Biochem J 368(Pt 1):171–182. doi:10.1042/BJ20020385
Park K, Oh D, Shin SY, Hahm KS, Kim Y (2002b) Structural studies of porcine myeloid antibacterial peptide PMAP-23 and its analogues in DPC micelles by NMR spectroscopy. Biochem Biophys Res Commun 290(1):204–212. doi:10.1006/bbrc.2001.6173
Pena OM, Afacan N, Pistolic J, Chen C, Madera L, Falsafi R et al (2013) Synthetic cationic peptide IDR-1018 modulates human macrophage differentiation. PLoS One 8(1):e52449. doi:10.1371/journal.pone.0052449
Peschel A, Sahl HG (2006) The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat Rev Microbiol 4(7):529–536. doi:10.1038/nrmicro1441
Raj PA, Dentino AR (2002) Current status of defensins and their role in innate and adaptive immunity. FEMS Microbiol Lett 206(1):9–18
Raj PA, Marcus E, Sukumaran DK (1998) Structure of human salivary histatin 5 in aqueous and nonaqueous solutions. Biopolymers 45(1):51–67. doi:10.1002/(sici)1097-0282(199801)45:1<51::aid-bip5>3.0.co;2-y
Riciluca KC, Sayegh RS, Melo RL, Silva PI Jr (2012) Rondonin an antifungal peptide from spider (Acanthoscurria rondoniae) haemolymph. Results Immunol 2:66–71. doi:10.1016/j.rinim.2012.03.001
Risso A, Braidot E, Sordano MC, Vianello A, Macri F, Skerlavaj B et al (2002) BMAP-28, an antibiotic peptide of innate immunity, induces cell death through opening of the mitochondrial permeability transition pore. Mol Cell Biol 22(6):1926–1935
Rodriguez-Cerdeira C, Arenas R, Moreno-Coutino G, Vasquez E, Fernandez R, Chang P (2014) Systemic fungal infections in patients with human immunodeficiency virus. Actas Dermosifiliogr 105(1):5–17. doi:10.1016/j.ad.2012.06.017
Rollins-Smith LA, Carey C, Conlon JM, Reinert LK, Doersam JK, Bergman T et al (2003) Activities of temporin family peptides against the chytrid fungus (Batrachochytrium dendrobatidis) associated with global amphibian declines. Antimicrob Agents Chemother 47(3):1157–1160
Rothstein DM, Spacciapoli P, Tran LT, Xu T, Roberts FD, Dalla Serra M et al (2001) Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5. Antimicrob Agents Chemother 45(5):1367–1373. doi:10.1128/aac.45.5.1367-1373.2001
Roversi D, Luca V, Aureli S, Park Y, Mangoni ML, Stella L (2014) How many antimicrobial peptide molecules kill a bacterium? The case of PMAP-23. ACS Chem Biol 9(9):2003–2007. doi:10.1021/cb500426r
Ryu JS, Cho AY, Seo SW, Min H (2014) Engineering bioactive peptide-based therapeutic molecules. Methods Mol Biol 1088:35–50. doi:10.1007/978-1-62703-673-3_3
Sabatini LM, Azen EA (1989) Histatins, a family of salivary histidine-rich proteins, are encoded by at least two loci (HIS1 and HIS2). Biochem Biophys Res Commun 160(2):495–502
Sachdeva V, Zhou Y, Banga AK (2013) In vivo transdermal delivery of leuprolide using microneedles and iontophoresis. Curr Pharm Biotechnol 14(2):180–193
Saravanan R, Joshi M, Mohanram H, Bhunia A, Mangoni ML, Bhattacharjya S (2013) NMR structure of temporin-1 ta in lipopolysaccharide micelles: mechanistic insight into inactivation by outer membrane. PLoS One 8(9):e72718. doi:10.1371/journal.pone.0072718
Savelyeva A, Ghavami S, Davoodpour P, Asoodeh A, Los MJ (2014) An overview of Brevinin superfamily: structure, function and clinical perspectives. Adv Exp Med Biol 818:197–212. doi:10.1007/978-1-4471-6458-6_10
Schoffelmeer EA, Klis FM, Sietsma JH, Cornelissen BJ (1999) The cell wall of Fusarium oxysporum. Fungal Genet Biol: FG & B 27(2–3):275–282. doi:10.1006/fgbi.1999.1153
Selsted ME, Ouellette AJ (2005) Mammalian defensins in the antimicrobial immune response. Nat Immunol 6(6):551–557. doi:10.1038/ni1206
Selsted ME, Novotny MJ, Morris WL, Tang YQ, Smith W, Cullor JS (1992) Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils. J Biol Chem 267(7):4292–4295
Shai Y (1999) Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim Biophys Acta 1462(1–2):55–70
Shimamura M, Yamamoto Y, Ashino H, Oikawa T, Hazato T, Tsuda H et al (2004) Bovine lactoferrin inhibits tumor-induced angiogenesis. Int J Cancer J Int Cancer 111(1):111–116. doi:10.1002/ijc.20187
Shin SY, Park EJ, Yang ST, Jung HJ, Eom SH, Song WK et al (2001) Structure-activity analysis of SMAP-29, a sheep leukocytes-derived antimicrobial peptide. Biochem Biophys Res Commun 285(4):1046–1051. doi:10.1006/bbrc.2001.5280
Simmaco M, Mignogna G, Canofeni S, Miele R, Mangoni ML, Barra D (1996) Temporins, antimicrobial peptides from the European red frog Rana temporaria. Eur J Biochem/FEBS 242(3):788–792
Situ H, Balasubramanian SV, Bobek LA (2000) Role of alpha-helical conformation of histatin-5 in candidacidal activity examined by proline variants. Biochim Biophys Acta 1475(3):377–382
Skerlavaj B, Benincasa M, Risso A, Zanetti M, Gennaro R (1999) SMAP-29: a potent antibacterial and antifungal peptide from sheep leukocytes. FEBS Lett 463(1–2):58–62
Steckbeck JD, Deslouches B, Montelaro RC (2014) Antimicrobial peptides: new drugs for bad bugs? Expert Opin Biol Ther 14(1):11–14. doi:10.1517/14712598.2013.844227
Steiner H, Andreu D, Merrifield RB (1988) Binding and action of cecropin and cecropin analogues: antibacterial peptides from insects. Biochim Biophys Acta 939(2):260–266
Steinstraesser L, Kraneburg U, Jacobsen F, Al-Benna S (2011) Host defense peptides and their antimicrobial-immunomodulatory duality. Immunobiology 216(3):322–333, doi:http://dx.doi.org/10.1016/j.imbio.2010.07.003
Steinstraesser L, Hirsch T, Schulte M, Kueckelhaus M, Jacobsen F, Mersch EA et al (2012) Innate defense regulator peptide 1018 in wound healing and wound infection. PLoS One 7(8):e39373. doi:10.1371/journal.pone.0039373
Suarez-Carmona M, Hubert P, Delvenne P, Herfs M (2014) Defensins: “Simple” antimicrobial peptides or broad-spectrum molecules? Cytokine Growth Factor Rev. doi:10.1016/j.cytogfr.2014.12.005
Sugiyama K, Suzuki Y, Furuta H (1985) Isolation and characterization of histamine-releasing peptides from human parotid saliva. Life Sci 37(5):475–480
Tack BF, Sawai MV, Kearney WR, Robertson AD, Sherman MA, Wang W et al (2002) SMAP-29 has two LPS-binding sites and a central hinge. Eur J Biochem/FEBS 269(4):1181–1189
Takahashi D, Shukla SK, Prakash O, Zhang G (2010) Structural determinants of host defense peptides for antimicrobial activity and target cell selectivity. Biochimie 92(9):1236–1241, doi:http://dx.doi.org/10.1016/j.biochi.2010.02.023
Tanida T, Okamoto T, Ueta E, Yamamoto T, Osaki T (2006) Antimicrobial peptides enhance the candidacidal activity of antifungal drugs by promoting the efflux of ATP from Candida cells. J Antimicrob Chemother 57(1):94–103. doi:10.1093/jac/dki402
Theis T, Stahl U (2004) Antifungal proteins: targets, mechanisms and prospective applications. Cell Mol Life Sci: CMLS 61(4):437–455. doi:10.1007/s00018-003-3231-4
Tielens AG, Rotte C, van Hellemond JJ, Martin W (2002) Mitochondria as we don’t know them. Trends Biochem Sci 27(11):564–572
Tsai H, Bobek LA (1997) Human salivary histatin-5 exerts potent fungicidal activity against Cryptococcus neoformans. Biochim Biophys Acta (BBA) Gen Subj 1336(3):367–369, doi:http://dx.doi.org/10.1016/S0304-4165(97)00076-7
van der Weerden NL, Bleackley MR, Anderson MA (2013) Properties and mechanisms of action of naturally occurring antifungal peptides. Cell Mol Life Sci: CMLS 70(19):3545–3570. doi:10.1007/s00018-013-1260-1
Viejo-Diaz M, Andres MT, Perez-Gil J, Sanchez M, Fierro JF (2003) Potassium efflux induced by a new lactoferrin-derived peptide mimicking the effect of native human lactoferrin on the bacterial cytoplasmic membrane. Biochem Biokhim 68(2):217–227
Viejo-Diaz M, Andres MT, Fierro JF (2004) Effects of human lactoferrin on the cytoplasmic membrane of Candida albicans cells related with its candidacidal activity. FEMS Immunol Med Microbiol 42(2):181–185. doi:10.1016/j.femsim.2004.04.005
Wade D, Silberring J, Soliymani R, Heikkinen S, Kilpelainen I, Lankinen H et al (2000) Antibacterial activities of temporin A analogs. FEBS Lett 479(1–2):6–9
Wang G (2008) Structures of human host defense cathelicidin LL-37 and its smallest antimicrobial peptide KR-12 in lipid micelles. J Biol Chem 283(47):32637–32643. doi:10.1074/jbc.M805533200
Wang P, Nan YH, Yang ST, Kang SW, Kim Y, Park IS et al (2010) Cell selectivity and anti-inflammatory activity of a Leu/Lys-rich alpha-helical model antimicrobial peptide and its diastereomeric peptides. Peptides 31(7):1251–1261. doi:10.1016/j.peptides.2010.03.032
Ward PP, Paz E, Conneely OM (2005) Multifunctional roles of lactoferrin: a critical overview. Cell Mol Life Sci: CMLS 62(22):2540–2548. doi:10.1007/s00018-005-5369-8
Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB (2004) Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis: Off Publ Infect Dis Soc Am 39(3):309–317. doi:10.1086/421946
Wong JH, Ye XJ, Ng TB (2013) Cathelicidins: peptides with antimicrobial, immunomodulatory, anti-inflammatory, angiogenic, anticancer and procancer activities. Curr Protein Pept Sci 14(6):504–514
Wong-Beringer A, Jacobs RA, Guglielmo BJ (1998) Lipid formulations of amphotericin B: clinical efficacy and toxicities. Clin Infect Dis: Off Publ Infect Dis Soc Am 27(3):603–618
Wunder D, Dong J, Baev D, Edgerton M (2004) Human salivary histatin 5 fungicidal action does not induce programmed cell death pathways in Candida albicans. Antimicrob Agents Chemother 48(1):110–115
Xu X, Lai R (2015) The chemistry and biological activities of peptides from amphibian skin secretions. Chem Rev 115(4):1760–1846. doi:10.1021/cr4006704
Xu Y, Ambudkar I, Yamagishi H, Swaim W, Walsh TJ, O’Connell BC (1999) Histatin 3-mediated killing of Candida albicans: effect of extracellular salt concentration on binding and internalization. Antimicrob Agents Chemother 43(9):2256–2262
Yang S, Jung, H., Kim J (2009) Solution structure of BMAP-27. doi:10.2210/pdb2ket/pdb
Yang L, Harroun TA, Weiss TM, Ding L, Huang HW (2001) Barrel-stave model or toroidal model? A case study on melittin pores. Biophys J 81(3):1475–1485. doi:10.1016/S0006-3495(01)75802-X
Yeaman MR, Yount NY (2003) Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev 55(1):27–55. doi:10.1124/pr.55.1.2
Yount NY, Bayer AS, Xiong YQ, Yeaman MR (2006) Advances in antimicrobial peptide immunobiology. Biopolymers 84(5):435–458. doi:10.1002/bip.20543
Yu S, Chai X, Wang Y, Cao Y, Zhang J, Wu Q et al (2014) Triazole derivatives with improved in vitro antifungal activity over azole drugs. Drug Des Devel Ther 8:383–390. doi:10.2147/DDDT.S58680
Zanetti M (2005) The role of cathelicidins in the innate host defenses of mammals. Curr Issues Mol Biol 7(2):179–196
Zanetti M, Gennaro R, Romeo D (1995) Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett 374(1):1–5
Zasloff M (2002) Antimicrobial peptides of multicellular organisms. Nature 415(6870):389–395. doi:10.1038/415389a
Zhai B, Zhou H, Yang L, Zhang J, Jung K, Giam CZ et al (2010) Polymyxin B, in combination with fluconazole, exerts a potent fungicidal effect. J Antimicrob Chemother 65(5):931–938. doi:10.1093/jac/dkq046
Zhang J, Movahedi A, Xu J, Wang M, Wu X, Xu C et al (2015) In vitro production and antifungal activity of peptide ABP-dHC-cecropin A. J Biotechnol 199C:47–54. doi:10.1016/j.jbiotec.2015.02.018
Zhao L, Tolbert WD, Ericksen B, Zhan C, Wu X, Yuan W et al (2013) Single, double and quadruple alanine substitutions at oligomeric interfaces identify hydrophobicity as the key determinant of human neutrophil alpha defensin HNP1 function. PLoS One 8(11):e78937. doi:10.1371/journal.pone.0078937
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer India
About this chapter
Cite this chapter
Freitas, C.G., Franco, O.L. (2016). Antifungal Peptides with Potential Against Pathogenic Fungi. In: Basak, A., Chakraborty, R., Mandal, S. (eds) Recent Trends in Antifungal Agents and Antifungal Therapy. Springer, New Delhi. https://doi.org/10.1007/978-81-322-2782-3_3
Download citation
DOI: https://doi.org/10.1007/978-81-322-2782-3_3
Published:
Publisher Name: Springer, New Delhi
Print ISBN: 978-81-322-2780-9
Online ISBN: 978-81-322-2782-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)